Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleElevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy.AuthorsVo, M.; Evans, M.; Leitzel, K.; Ali, S.; Wilson, M.; Demers, L.; Evans, D.; Lipton, A.PublicationBreast Cancer Research & Treatment, 2010, Vol 119, Issue 3, p767ISSN0167-6806Publication typeReportDOI10.1007/s10549-008-0261-5